This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Phase I Small Business Innovation Research (SBIR) grant for $275,000 awarded to Ihnnova LLC aims to develop and evaluate a hand-held induction heater system for treating pancreatic and prostate cancer using magnetic fluid hyperthermia (MFH) technology. The project seeks to advance the proposed technology from laboratory validation to a relevant environment, with the goal of enabling MFH cancer treatment for patients with metallic implants who are currently ineligible due to safety concerns. The key objectives are to (A) deliver significant thermal energy to pancreatic and prostate tissues in porcine models, and (B) characterize the extent and severity of tissue damage. If successful, this innovation could open up MFH cancer treatment to an estimated 2 million additional patients annually who have metallic implants. The project will be conducted in Mayagüez, Puerto Rico, and sub-awards are planned as part of the grant.
Generated 4/1/25, 4:00 AM